Vol 5, No 3 (June 01, 2016): Chinese Clinical Oncology (Multidisciplinary Management of Breast Cancer-Guest Editors: Charles M. Balch, Ning Liao, Kelly K. Hunt)

Editorial

Management of invasive and non-invasive breast cancer in the United States and China

Ning Liao, Kelly K. Hunt, Charles M. Balch

PDF Pages: 30 Full Text (4778) Open Access

Review Article

The United States’ national accreditation program for breast centers: a model for excellence in breast disease evaluation and management

David P. Winchester

PDF Pages: 31 Full Text (7453) Open Access

Contemporary management of ductal carcinoma in situ and lobular carcinoma in situ

Samilia Obeng-Gyasi, Cecilia Ong, E. Shelley Hwang

PDF Pages: 32 Full Text (15190) Open Access

Ultrasound image-guided core biopsy of the breast

V. Suzanne Klimberg, Amy Rivere

PDF Pages: 33 Full Text (17885) Open Access

Advances in the surgical treatment of breast cancer

Lei Xing, Qiang He, Yuan-Yuan Wang, Hong-Yuan Li, Guo-Sheng Ren

PDF Pages: 34 Full Text (9852) Open Access

Appropriate margin for lumpectomy excision of invasive breast cancer

Andrea V. Barrio, Monica Morrow

PDF Pages: 35 Full Text (14316) Open Access

The staging value of sentinel lymph node biopsy for breast cancer: translating pathologic findings to clinical practice

Jean Bao, Cory Donovan, Alice Chung, Armando E. Giuliano

PDF Pages: 36 Full Text (10758) Open Access

The timing of breast and axillary surgery after neoadjuvant chemotherapy for breast cancer

Zahraa Al-Hilli, Judy C. Boughey

PDF Pages: 37 Full Text (34280) Open Access

Indications for adjuvant radiation therapy in breast cancer: a review of the evidence and recommendations for clinical practice

Cameron W. Swanick, Benjamin D. Smith

PDF Pages: 38 Full Text (29797) Open Access

Alternatives to whole breast irradiation in early breast cancer

V. Suzanne Klimberg, Amy Rivere, Loverd Peacock

PDF Pages: 39 Full Text (7071) Open Access

Endocrine therapy as adjuvant or neoadjuvant therapy for breast cancer: selecting the best agents, the timing and duration of treatment

Jun-Jie Li, Zhi-Min Shao

PDF Pages: 40 Full Text (10226) Open Access

HER2-positive breast cancer, how far away from the cure?—on the current situation of anti-HER2 therapy in breast cancer treatment and survival of patients

Ning Liao

PDF Pages: 41 Full Text (11579) Open Access

Chemotherapy principles of managing stage IV breast cancer in the United States

Leonel F. Hernandez-Aya, Cynthia X. Ma

PDF Pages: 42 Full Text (16931) Open Access

Training of breast surgical oncologists

Mediget Teshome, Henry M. Kuerer

PDF Pages: 43 Full Text (8561) Open Access

The role of Advanced Practice Providers in interdisciplinary oncology care in the United States

Rae Brana Reynolds, Kimberly McCoy

PDF Pages: 44 Full Text (13445) Open Access

Organizing a breast cancer database: data management

Min Yi, Kelly K. Hunt

PDF Pages: 45 Full Text (7872) Open Access

The way to precision medicine of our team

Fengrui Xu, Xiaodi Wang, Zefei Jiang

PDF Pages: 46 Full Text (9178) Open Access

Genetic testing for hereditary breast cancer in Asia—moving forward

Ava Kwong

PDF Pages: 47 Full Text (10417) Open Access

Disclosure:

The focused issue “Multidisciplinary Management of Breast Cancer” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Charles M. Balch, Ning Liao and Kelly K. Hunt served as the unpaid Guest Editors for the focused issue.